A new study under consideration at BMC Microbiology and published on the Research Square* preprint server describes a potential relationship between antibody titers against the rubella virus and the ...

In Portugal, the recommended age for the second dose of MMR (MMR2) was changed from 10–13 years to 5–6 years for those born in 1994 and afterwards. This study aimed to assess if MMR schedule and time ...

People with lower levels of antibodies against mumps -- the second "M" in the MMR vaccine -- are likelier to have a severe case of COVID. Vaccines must be rigorously tested before they are deployed en ...

When public health officials make policies about when and how vaccination programs are implemented, they must weigh the benefits and risks of how infectious diseases spread throughout the country.

Passive immunization is a method that helps prevent rubella in those who are exposed or susceptible to the disease. In this strategy, ready-made IgG antibodies against rubella are administered.

An international team developed a new model, based on a case study of Nigeria, that may help public health officials accelerate the introduction of rubella vaccination in countries that have yet to do ...

Virion\Serion presents a novel recombinant Rubella spike ectodomain (E1-E2) antigen in comparison with established IVD Rubella IgM assays. The IgM antibodies are detected on magnetic beads coated with ...

Dear Dr. Roach: You recently wrote that "nearly everybody born before 1957 had measles and mumps (but not rubella)." I was born in the early 1950s, so I fall into this category. A few years ago, at my ...

When Kishana Taylor welcomes her twins into the world this December, she’ll be pretty confident that they won’t be carrying the virus that causes rubella, an infection that can be disastrous in ...

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early ...